This SMF briefing gives a background to what will change under Universal Credit, sets out who will be affected, and highlights future issues of concern.
Following recent controversies over the availability of expensive drugs on the NHS, NICE’s work in allocating the NHS’s spending on medical treatments is coming under increasing scrutiny. In this essay, Professor Paul Dolan challenges the methodology used by NICE to determine the cost-effectiveness of different treatments.
General Health Co-operative (GHC) in Seattle has sold its last hospital. In future GHC will provide healthcare to over 600,000 people by using hospitals belonging to other organisations.
